article thumbnail

Schedule III Marijuana Would Still Be Regulated Marijuana

FDA Law Blog: Biosimilars

In January a public hearing began to receive factual evidence and testimony on whether marijuana should be rescheduled. DEA published a Notice of Proposed Rulemaking (NPRM), signed by Attorney General Merrick Garland, proposing to reschedule marijuana in May 2024 that elicited over 43,500 comments.

article thumbnail

R&D Partnering Testimonials from Bayer, Oldcastle and Joyn Bio

Translation

Companies invest more than $2 trillion in R&D annually to stay ahead of competition, identify new products, and find new sources of revenue. Oldcastle’s stormwater products are widely used, including by Quantico National Cemetery, Los Angeles International Airport, and The Atlanta Braves’ and San Francisco 49ers’ stadiums.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bogus ‘Cure’ Claims Have U.S. Consumers Snapping Up CBD Products

The Pharma Data

The wave of marijuana legalization in the United States has led to a massive surge of CBD products being marketed across the nation, researchers said. A random sample of 376 posts labeled testimonials found that 90% cited using CBD to treat diagnosable medical conditions. © 2020 HealthDay. All rights reserved. Posted: October 2020.

article thumbnail

Digital Product Catalog: The Medical Device Marketer’s Guide

Perficient: Drug Development

Your products are cutting-edge, innovative, and best-in-class. But here is the big question: Is the experience your digital product catalog delivers as innovative as y our products ? Often, the answer is “No,” and that’s not surprising. But do they truly showcase what makes the product compelling? But can we go deeper?

article thumbnail

October CMS: A Modern CMS for Developers and Creators

Perficient: Drug Development

testimonials or client inquiries). Both plugins allow product management, order processing, payment integration, and customer management. It facilitates clean code management, quick development, and the production of unique plugins. Supports digital and physical products, custom attributes, and variants (like sizes or colors).

article thumbnail

New FDA guidance on addressing misinformation under White House review

Agency IQ

BY LAURA DIANGELO, MPH A new question-and-answer draft guidance document focused on “addressing misinformation” about regulated life sciences products is currently under administrative review at the White House’s Office of Information and Regulatory Affairs (OIRA). Fill out the form to read the full article.

FDA 59
article thumbnail

The Growing Trend of Patient-Led Clinical Research in Rare Disease

Conversations in Drug Development Trends

These meetings are designed for attendees to hear testimonies from clinicians, patients, caregivers, and families about the issues facing these stakeholder groups in the diagnosis, treatment, and long-term prognosis of a disease as it is experienced in real life – not through an impersonal, peer-reviewed case report.